Healthcare & Pharmaceuticals

From patient care to innovation, we're supporting the future of healthcare.

Overview

About 10% of Australia's GDP is spent on health. What are we getting for that? We get more than just a trip to the doctor, that's for sure. Modern healthcare encompasses extraordinary technical advances, commercialisation, patents, trade marks and other IP, and a highly regulated pharmaceutical sector.

There's innovation too in the way health services are developed and delivered, from research and health precincts through to healthcare infrastructure such as hospitals or aged care homes which integrate the latest technology with old-fashioned care and compassion. For those running a healthcare facility, there are also medical negligence and disciplinary proceedings. Underlying it all is the need to protect, manage and utilise vast amounts of sensitive data within strict privacy laws. And then there are the business issues: corporate governance, real estate acquisition, planning approvals, investments, and exit strategies.

We might not be able to solve physical headaches as easily as you can, but we know how to deal with the legal headaches – and even stop them from happening.

Our team to support you

Insights
Significant recalibration to notification thresholds in Australia’s merger control reforms
24 Dec 2025 | Article
Read Insights
Consultation opens to strengthen corporate transparency under Australia's Director Identification Number regime
18 Dec 2025 | Article
Read Insights
ACCC merger reforms coming 1 January 2026 – considerations for serial acquirers
12 Dec 2025 | Article
Read Insights
Shareholder say is back: ASX’s consultation on dilutive deals, delistings and the new mood of investor activism
11 Dec 2025 | Article
Read Insights
Full Federal Court abolishes patent term extensions for pharmaceutical formulations
8 Dec 2025 | Article
Read Insights
Work Health and Safety Regulation 2025 (NSW) – key changes
26 Nov 2025 | Article
Read Insights
COP30 Belém wraps up – Resolving to go faster, slowly at the COP of (hard) truth
26 Nov 2025 | Article
Read Insights
Wage underpayment class actions: How to prepare for what is coming next
26 Nov 2025 | Article
Read Insights
COP30 Week One: What Australian businesses need to know
19 Nov 2025 | Article
Read Insights
No sure exit: Court confirms high bar to terminate M&A transaction based on a material adverse change
7 Nov 2025 | Article
Read Insights
Court-ordered action: How a mandatory injunction can be used to secure contractual performance
6 Nov 2025 | Article
Read Insights
Consultation open to streamline and strengthen Australia's foreign investment framework
6 Nov 2025 | Article
Read Insights